LIF Form 4: Director Disposes of Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
John Philip Coghlan, a director of Life360, Inc. (LIF), reported multiple dispositions of common stock effected on 10/01/2025. The filing shows sales under a Rule 10b5-1 trading plan adopted on 12/06/2024. Reported transactions include dispositions of 2,701 shares at a weighted average price of $105.28 (prices ranged $104.84–$105.73), 424 shares at a weighted average of $105.99 (range $105.84–$106.05), and 3,344 shares (note: includes 2,508 restricted stock units) with beneficial ownership changes reported as indirect holdings in the John Coghlan Living Trust and the John Philip Coghlan 2025 Grantor Retained Annuity Trust. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Positive
- Dispositions executed under a Rule 10b5-1 plan adopted on 12/06/2024
- Price ranges and weighted averages disclosed (e.g., $104.84–$105.73, $105.84–$106.05)
Negative
- Director reported multiple sales of common stock on 10/01/2025 (2,701; 424; 3,344 shares)
- 3,344-share disposition includes 2,508 restricted stock units, reducing potential future vested holdings
Insights
Director sold shares under a pre-set 10b5-1 plan, reporting multiple dispositions at roughly $105 per share.
The Form 4 discloses sales on 10/01/2025 executed via a Rule 10b5-1 plan adopted on 12/06/2024, indicating the trades were pre-arranged and executed automatically. The filing lists weighted average prices and inclusive price ranges for the transactions.
This matters because 10b5-1 sales are generally pre-planned, which reduces the likelihood that the sales were based on material nonpublic information, though the market often interprets insider sales as useful context.
Dispositions are held indirectly through trusts, and a portion arose from restricted stock units.
The filing shows indirect holdings in the John Coghlan Living Trust and the John Philip Coghlan 2025 Grantor Retained Annuity Trust, and notes 2,508 restricted stock units included in a reported disposition. The use of trusts and RSUs is common for executive holdings and tax/estate planning.
Investors can confirm the mechanics (trusts, RSUs, and 10b5-1 plan) from the disclosed text; no additional corporate actions or compensation changes are reported here.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common stock | 2,701 | $105.28 | $284K |
| Sale | Common stock | 424 | $105.99 | $45K |
| holding | Common stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $104.84 to $105.73, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $105.84 to $106.05, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. Includes 2,508 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
